Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/edleCfbwoceWwqxBuSsy

December 24, 2012
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • Study: FDG-PET/CT performs well in diagnosing metastases
    Findings from a meta-analysis published in the Journal of Nuclear Medicine showed that whole-body FDG-PET/CT has overall 93% sensitivity and 96% specificity in diagnosing distant malignancies in patients who have head and neck, breast and lung cancers. The researchers assessed 41 studies from Medline and Embase that looked into the use of whole-body PET/CT in analyzing cancer metastases. The results indicate the hybrid modality is capable of "excellent diagnostic performance for the detection of distant malignancies in patients with various cancers, especially head and neck cancer, breast cancer, and lung cancer," the researchers said. AuntMinnie.com (free registration) (12/21) LinkedInFacebookTwitterEmail this Story
  Clinical News & Research 
  • Researchers find biomarkers for Kawasaki disease
    Researchers using mass spectrometry and enzyme-linked immunosorbant screenings have identified 190 proteins in urine samples from children with Kawasaki disease that can serve as biomarkers for quicker diagnosis of the disease, according to a study published in the journal EMBO Molecular Medicine. The data suggest levels of the proteins may indicate treatment response and, in the case of one patient, recurrence. News-Medical.Net/News release (12/20) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  • Report projects continued decline in contrast agents, radiopharma
    Decreased reimbursements and payer restrictions will hold down the growth of the U.S. contrast agent and radiopharmaceutical market, according to a report from Millennium Research Group. These factors, as well as competition, fueled a 15% market decline between 2010 and 2012. The trend is expected to continue through 2017, although it will be moderated by the expected increase in demand among the growing elderly population, according to the report. Business Wire/News release (12/20) LinkedInFacebookTwitterEmail this Story
  International Developments 
  Health Policy 
  Advancing Health Care 
  • More hospitals, providers receive EHR incentive payments
    Three-quarters of eligible hospitals and one-third of doctors and other eligible professionals have received incentive payments for EHR system adoption, data from CMS reveal. A total of $9.3 billion has been released since the incentive program launched, with $6.1 billion going to eligible hospitals and $3.1 billion directed to doctors and other eligible professionals, the agency's November report shows. Modern Healthcare (subscription required) (12/21) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • Happy Holidays from SNMMI!
    LinkedInFacebookTwitterEmail this Story
  • New self-assessment modules (SAMs) available!
    Take advantage of new Journal SAMs and earn credit before the end of the year! Popular SAMs include "Bringing Physiology into PET of the Liver," "Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias," "Modern Nuclear Imaging for Paragangliomas: Beyond SPECT" and "Effectiveness and Safety of FDG-PET in the Evaluation of Dementia." Get started today. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  Editor's Note 
  • SmartBrief will not publish Tuesday
    In observance of Christmas, SmartBrief will not publish Tuesday. Publication will resume Wednesday. Enjoy the holiday! LinkedInFacebookTwitterEmail this Story
  SmartQuote 
In seed time learn, in harvest teach, in winter enjoy."
--William Blake,
British poet and painter


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.®  Legal Information